The myotonic dystrophies: molecular, clinical, and therapeutic challengesBjarne Udd, Ralf Krahe|The Lancet Neurology|2012Cited by 487
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2Anna Vihola, Bjarne Udd, Guillaume Bassez et al.|Neurology|2003Cited by 173
Confirmation of the Type 2 Myotonic Dystrophy (CCTG) Expansion Mutation in Patients with Proximal Myotonic Myopathy/Proximal Myotonic Dystrophy of Different European Origins: A Single Shared Haplotype Indicates an Ancestral Founder EffectLinda L. Bachinski, Ralf Krahe, Bjarne Udd et al.|The American Journal of Human Genetics|2003Cited by 140
Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in FinlandTiina Suominen, Bjarne Udd, Linda L. Bachinski et al.|European Journal of Human Genetics|2011Cited by 135
140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on managementBjarne Udd, Richard T. Moxley, G. Meola et al.|Neuromuscular Disorders|2006Cited by 107